The companies had entered into an agreement in 2010 under which GSK had taken a license to formulation technology covered by a Vectura patent family.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.